BDTX: Black Diamond Therapeutics Inc Financial Statements
Balance sheet, income statement, and cash flow statements for Black Diamond Therapeutics Inc (BDTX).
$121.09M Market Cap.
BDTX Market Cap. (MRY)
BDTX Shares Outstanding (MRY)
BDTX Assets (MRY)
Total Assets
$122.64M
Total Liabilities
$39.35M
Total Investments
$62.14M
BDTX Income (MRY)
Revenue
$0
Net Income
-$69.68M
Operating Expense
$78.78M
BDTX Cash Flow (MRY)
CF Operations
-$62.30M
CF Investing
$16.97M
CF Financing
$25.55M
BDTX Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total Assets | $122,640,000 (-22.66%) | $158,567,000 (1.48%) | $156,255,000 (-36.91%) | $247,682,000 (-24.87%) |
Assets Current | $101,176,000 (-24.51%) | $134,034,000 (4.96%) | $127,706,000 (-40.80%) | $215,703,000 (-32.50%) |
Assets Non-Current | $21,464,000 (-12.51%) | $24,533,000 (-14.07%) | $28,549,000 (-10.73%) | $31,979,000 (216.12%) |
Goodwill & Intangible Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Shareholders Equity | $83,285,000 (-28.66%) | $116,736,000 (0.90%) | $115,695,000 (-40.94%) | $195,900,000 (-36.35%) |
Property Plant & Equipment Net | $20,396,000 (-13.98%) | $23,710,000 (-13.41%) | $27,381,000 (-10.93%) | $30,740,000 (249.83%) |
Cash & Equivalents | $37,256,000 (-34.69%) | $57,044,000 (60.76%) | $35,483,000 (-47.06%) | $67,022,000 (87.07%) |
Accumulated Other Comprehensive Income | $24,000 (188.89%) | -$27,000 (98.52%) | -$1,824,000 (-340.58%) | -$414,000 (-167.43%) |
Deferred Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Investments | $62,138,000 (-17.35%) | $75,179,000 (-15.04%) | $88,492,000 (-38.54%) | $143,987,000 (-48.66%) |
Investments Current | $62,138,000 (-17.35%) | $75,179,000 (-15.04%) | $88,492,000 (-38.54%) | $143,987,000 (-48.66%) |
Investments Non-Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Inventory | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Receivables | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Payables | $4,007,000 (72.42%) | $2,324,000 (23.81%) | $1,877,000 (-54.30%) | $4,107,000 (61.82%) |
Accumulated Retained Earnings (Deficit) | -$487,107,000 (-16.69%) | -$417,431,000 (-24.61%) | -$334,989,000 (-37.39%) | -$243,820,000 (-106.24%) |
Tax Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Tax Liabilities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Debt | $18,782,000 (-15.34%) | $22,185,000 (-12.31%) | $25,299,000 (-10.10%) | $28,140,000 (265.74%) |
Debt Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Debt Non-Current | $18,782,000 (-15.34%) | $22,185,000 (-12.31%) | $25,299,000 (-10.10%) | $28,140,000 (265.74%) |
Total Liabilities | $39,355,000 (-5.92%) | $41,831,000 (3.13%) | $40,560,000 (-21.67%) | $51,782,000 (136.32%) |
Liabilities Current | $20,573,000 (4.72%) | $19,646,000 (28.73%) | $15,261,000 (-35.45%) | $23,642,000 (66.28%) |
Liabilities Non-Current | $18,782,000 (-15.34%) | $22,185,000 (-12.31%) | $25,299,000 (-10.10%) | $28,140,000 (265.74%) |
BDTX Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Revenues | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Cost of Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Selling General & Administrative Expense | $27,469,000 (1.32%) | $27,110,000 (-4.51%) | $28,391,000 (-5.50%) | $30,043,000 (40.64%) |
Research & Development Expense | $51,312,000 (-13.54%) | $59,350,000 (-7.89%) | $64,437,000 (-33.45%) | $96,829,000 (100.85%) |
Operating Expenses | $78,781,000 (-8.88%) | $86,460,000 (-6.86%) | $92,828,000 (-26.83%) | $126,872,000 (82.37%) |
Interest Expense | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Income Tax Expense | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | -$69,676,000 (15.48%) | -$82,442,000 (9.57%) | -$91,169,000 (27.41%) | -$125,596,000 (-86.75%) |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income | -$69,676,000 (15.48%) | -$82,442,000 (9.57%) | -$91,169,000 (27.41%) | -$125,596,000 (-86.75%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income Common Stock | -$69,676,000 (15.48%) | -$82,442,000 (9.57%) | -$91,169,000 (27.41%) | -$125,596,000 (-86.75%) |
Weighted Average Shares | $55,028,371 (25.19%) | $43,954,649 (21.00%) | $36,325,586 (0.38%) | $36,189,002 (9.97%) |
Weighted Average Shares Diluted | $55,028,371 (25.19%) | $43,954,649 (21.00%) | $36,325,586 (0.38%) | $36,189,002 (9.97%) |
Earning Before Interest & Taxes (EBIT) | -$69,676,000 (15.48%) | -$82,442,000 (9.57%) | -$91,169,000 (27.41%) | -$125,596,000 (-86.75%) |
Gross Profit | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Operating Income | -$78,781,000 (8.88%) | -$86,460,000 (6.86%) | -$92,828,000 (26.83%) | -$126,872,000 (-82.37%) |
BDTX Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Net Cash Flow from Investing | $16,968,000 (3.81%) | $16,346,000 (-69.37%) | $53,366,000 (-59.14%) | $130,613,000 (146.37%) |
Net Cash Flow from Financing | $25,547,000 (-64.48%) | $71,932,000 (40539.55%) | $177,000 (-75.72%) | $729,000 (-99.66%) |
Net Cash Flow from Operations | -$62,303,000 (6.62%) | -$66,717,000 (21.59%) | -$85,082,000 (15.04%) | -$100,148,000 (-92.05%) |
Net Cash Flow / Change in Cash & Cash Equivalents | -$19,788,000 (-191.78%) | $21,561,000 (168.36%) | -$31,539,000 (-201.11%) | $31,194,000 (126.24%) |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | $16,874,000 (3.62%) | $16,284,000 (-69.59%) | $53,549,000 (-59.84%) | $133,323,000 (147.35%) |
Capital Expenditure | $94,000 (51.61%) | $62,000 (133.88%) | -$183,000 (93.25%) | -$2,710,000 (-1808.45%) |
Issuance (Repayment) of Debt Securities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Issuance (Purchase) of Equity Shares | $25,547,000 (-64.48%) | $71,932,000 (40539.55%) | $177,000 (-75.72%) | $729,000 (-99.66%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Share Based Compensation | $10,627,000 (10.65%) | $9,604,000 (-21.26%) | $12,197,000 (-13.11%) | $14,037,000 (80.77%) |
Depreciation Amortization & Accretion | $343,000 (-21.51%) | $437,000 (-13.98%) | $508,000 (147.80%) | $205,000 (294.23%) |
BDTX Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Gross Margin | - | - | - | - |
Profit Margin | - | - | - | - |
EBITDA Margin | - | - | - | - |
Return on Average Equity (ROAE) | -70.40% (7.85%) | -76.40% (-20.31%) | -63.50% (-19.59%) | -53.10% (-162.87%) |
Return on Average Assets (ROAA) | -50.40% (10.32%) | -56.20% (-16.36%) | -48.30% (-8.05%) | -44.70% (-130.41%) |
Return on Sales (ROS) | - | - | - | - |
Return on Invested Capital (ROIC) | -64.00% (18.68%) | -78.70% (-25.52%) | -62.70% (-18.08%) | -53.10% (-68.04%) |
Dividend Yield | 0% (0%) | 0% (0%) | 0% (0%) | 0% (0%) |
Price to Earnings Ratio (P/E) | -1.69 (-12.71%) | -1.5 (-109.38%) | -0.71 (53.52%) | -1.54 (90.18%) |
Price to Sales Ratio (P/S) | - | - | - | - |
Price to Book Ratio (P/B) | 1.45 (16.98%) | 1.24 (119.61%) | 0.57 (-42.60%) | 0.99 (-73.70%) |
Debt to Equity Ratio (D/E) | 0.47 (32.12%) | 0.36 (1.99%) | 0.35 (32.95%) | 0.26 (271.83%) |
Earnings Per Share (EPS) | -1.27 (32.45%) | -1.88 (25.40%) | -2.52 (27.38%) | -3.47 (-69.27%) |
Sales Per Share (SPS) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
Free Cash Flow Per Share (FCFPS) | -1.13 (25.46%) | -1.52 (35.41%) | -2.35 (17.42%) | -2.84 (-78.85%) |
Book Value Per Share (BVPS) | 1.51 (-43.03%) | 2.66 (-16.61%) | 3.19 (-41.16%) | 5.41 (-42.12%) |
Tangible Assets Book Value Per Share (TABVPS) | 2.23 (-38.22%) | 3.61 (-16.13%) | 4.3 (-37.14%) | 6.84 (-31.68%) |
Enterprise Value Over EBIT (EV/EBIT) | -2 (-100.00%) | -1 (0%) | 0 (0%) | -1 (93.75%) |
Enterprise Value Over EBITDA (EV/EBITDA) | -1.68 (-26.03%) | -1.33 (-232.42%) | -0.4 (71.11%) | -1.39 (91.55%) |
Asset Turnover | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
Current Ratio | 4.92 (-27.91%) | 6.82 (-18.48%) | 8.37 (-8.29%) | 9.12 (-59.40%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | -$62,209,000 (6.67%) | -$66,655,000 (21.83%) | -$85,265,000 (17.10%) | -$102,858,000 (-96.71%) |
Enterprise Value (EV) | $116,511,035 (6.60%) | $109,296,867 (200.49%) | $36,373,171 (-79.11%) | $174,090,802 (-84.23%) |
Earnings Before Tax (EBT) | -$69,676,000 (15.48%) | -$82,442,000 (9.57%) | -$91,169,000 (27.41%) | -$125,596,000 (-86.75%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$69,333,000 (15.45%) | -$82,005,000 (9.55%) | -$90,661,000 (27.70%) | -$125,391,000 (-86.59%) |
Invested Capital | $83,593,000 (-19.67%) | $104,062,000 (-20.45%) | $130,810,000 (-29.35%) | $185,158,000 (-35.56%) |
Working Capital | $80,603,000 (-29.54%) | $114,388,000 (1.73%) | $112,445,000 (-41.45%) | $192,061,000 (-37.10%) |
Tangible Asset Value | $122,640,000 (-22.66%) | $158,567,000 (1.48%) | $156,255,000 (-36.91%) | $247,682,000 (-24.87%) |
Market Capitalization | $121,092,035 (-16.54%) | $145,094,867 (121.66%) | $65,459,171 (-66.10%) | $193,099,802 (-83.26%) |
Average Equity | $99,009,500 (-8.21%) | $107,860,500 (-24.82%) | $143,464,250 (-39.38%) | $236,655,250 (-29.01%) |
Average Assets | $138,260,750 (-5.69%) | $146,602,500 (-22.33%) | $188,746,750 (-32.77%) | $280,737,250 (-19.12%) |
Invested Capital Average | $108,833,750 (3.85%) | $104,799,500 (-27.97%) | $145,499,750 (-38.49%) | $236,542,000 (11.22%) |
Shares | 56,585,063 (9.59%) | 51,635,184 (41.99%) | 36,366,206 (0.38%) | 36,228,856 (0.65%) |
